BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 11445740)

  • 1. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.
    Levi M; de Jonge E; van der Poll T
    Crit Care Med; 2001 Jul; 29(7 Suppl):S90-4. PubMed ID: 11445740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.
    Esmon CT
    Crit Care Med; 2001 Jul; 29(7 Suppl):S48-51; discussion 51-2. PubMed ID: 11445734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.
    Faust SN; Heyderman RS; Levin M
    Crit Care Med; 2001 Jul; 29(7 Suppl):S62-7; discussion S67-8. PubMed ID: 11445736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular coagulopathy and disseminated intravascular coagulation.
    ten Cate H; Schoenmakers SH; Franco R; Timmerman JJ; Groot AP; Spek CA; Reitsma PH
    Crit Care Med; 2001 Jul; 29(7 Suppl):S95-7; discussion S97-8. PubMed ID: 11445741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis and disseminated intravascular coagulation.
    Levi M; de Jonge E; van der Poll T
    J Thromb Thrombolysis; 2003; 16(1-2):43-7. PubMed ID: 14760211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anticoagulant strategies on activation of inflammation and coagulation.
    Feistritzer C; Wiedermann CJ
    Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
    Iba T; Nagaoka I; Boulat M
    Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to the management of disseminated intravascular coagulation.
    Levi M; de Jonge E; van der Poll T; ten Cate H
    Crit Care Med; 2000 Sep; 28(9 Suppl):S20-4. PubMed ID: 11007192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology.
    Levi M; de Jonge E; van der Poll T
    Ann Med; 2004; 36(1):41-9. PubMed ID: 15000346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation inhibitors in severe sepsis: state of the art].
    Fourrier F
    Rev Med Interne; 2003 May; 24(5):295-304. PubMed ID: 12763175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan.
    Iba T; Gando S; Thachil J
    J Thromb Haemost; 2014 Jul; 12(7):1010-9. PubMed ID: 24801203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.
    Hook KM; Abrams CS
    Clin Transl Sci; 2012 Feb; 5(1):85-92. PubMed ID: 22376264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.
    Umemura Y; Yamakawa K; Ogura H; Yuhara H; Fujimi S
    J Thromb Haemost; 2016 Mar; 14(3):518-30. PubMed ID: 26670422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation: What's new?
    Levi M
    Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation inhibitor substitution during sepsis.
    Fourrier F; Jourdain M; Tournois A; Caron C; Goudemand J; Chopin C
    Intensive Care Med; 1995 Nov; 21 Suppl 2():S264-8. PubMed ID: 8636534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coagulant response in sepsis.
    Levi M
    Clin Chest Med; 2008 Dec; 29(4):627-42, viii. PubMed ID: 18954698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.